Illumina, Inc. (ILMN)
134.87
-1.57
(-1.15%)
USD |
NASDAQ |
Dec 12, 16:00
134.96
+0.09
(+0.07%)
After-Hours: 20:00
Illumina Research and Development Expense (Quarterly): 228.00M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| GeneDx Holdings Corp. | 19.59M |
| Guardant Health, Inc. | 89.96M |
| EXACT Sciences Corp. | 117.22M |
| Waters Corp. | 53.64M |
| Natera, Inc. | 173.41M |